Richman Eric I Insider Trades

Insider Trading History

Track insider trading activity for Richman Eric I. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Gain Therapeutics
Gain Therapeutics GANX
Director
Holding Value $27.9k 15,000 shares
Last Trade
Jun 24, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$26.9k 15,000 shares
$1.79
$1.86
Gain Therapeutics
Gain Therapeutics GANX
Director
Holding Value $539k 289,629 shares
Last Trade
Jul 01, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$20.7k 17,000 shares
$1.22
$1.86
Gain Therapeutics
Gain Therapeutics GANX
Director
Holding Value $27.9k 15,000 shares
Last Trade
Jun 24, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$19.4k 15,000 shares
$1.29
$1.86
Gain Therapeutics
Gain Therapeutics GANX
Director
Holding Value $0 0 shares
Last Trade
Sep 20, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$187k 54,900 shares
$3.40
$1.86
Gain Therapeutics
Gain Therapeutics GANX
Director
Holding Value $507k 272,629 shares
Last Trade
Sep 20, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$187k 54,900 shares
$3.40
$1.86
Gain Therapeutics
Gain Therapeutics GANX
Director
Holding Value $613k 329,400 shares
Last Trade
Sep 20, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.15M 329,400 shares
$3.50
$1.86
Gain Therapeutics
Gain Therapeutics GANX
Director
Holding Value $102k 54,900 shares
Last Trade
Sep 20, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$192k 54,900 shares
$3.50
$1.86
NeuBase Therapeutics
NeuBase Therapeutics NBSE
Director
Holding Value $14.2k 37,600 shares
Last Trade
Sep 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.96M 37,600 shares
$238.20
$0.38
Gain Therapeutics
Gain Therapeutics GANX
Director, CHIEF EXECUTIVE OFFICER
Holding Value $405k 217,729 shares
Last Trade
May 25, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$6.4k 2,482 shares
$2.58
$1.86
Gain Therapeutics
Gain Therapeutics GANX
Director, CHIEF EXECUTIVE OFFICER
Holding Value $400k 215,247 shares
Last Trade
May 19, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$26.2k 9,256 shares
$2.83
$1.86
NeuBase Therapeutics
NeuBase Therapeutics NBSE
Director
Holding Value $17k 44,960 shares
Last Trade
Mar 04, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$620k 1,000 shares
$620.00
$0.38
NeuBase Therapeutics
NeuBase Therapeutics NBSE
Director
Holding Value $16.1k 42,660 shares
Last Trade
Mar 01, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.11M 1,580 shares
$700.00
$0.38
NeuBase Therapeutics
NeuBase Therapeutics NBSE
Director
Holding Value $16.6k 43,960 shares
Last Trade
Mar 01, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$910k 1,300 shares
$700.00
$0.38
NeuBase Therapeutics
NeuBase Therapeutics NBSE
Director
Holding Value $14.4k 38,135 shares
Last Trade
Aug 19, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$51.3M 38,135 shares
$1,344.00
$0.38
Gain Therapeutics
Gain Therapeutics GANX
Director
Holding Value $403k 216,820 shares
Last Trade
Aug 16, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$38.7k 4,922 shares
$7.87
$1.86
Gain Therapeutics
Gain Therapeutics GANX
Chief Executive Officer
Holding Value $403k 216,820 shares
Last Trade
Aug 16, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$38.7k 4,922 shares
$7.87
$1.86
NeuBase Therapeutics
NeuBase Therapeutics NBSE
Director
Holding Value $15.5k 41,080 shares
Last Trade
Apr 26, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$11.4M 5,000 shares
$2,280.00
$0.38
Gain Therapeutics
Gain Therapeutics GANX
Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Mar 17, 2021 Sale
No data
No data
$1.86
NeuBase Therapeutics
NeuBase Therapeutics NBSE
Director
Holding Value $5.53k 14,634 shares
Last Trade
Sep 09, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$51.5M 14,634 shares
$3,520.00
$0.38
NeuBase Therapeutics
NeuBase Therapeutics NBSE
Director
Holding Value $13.6k 36,080 shares
Last Trade
Apr 30, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$25.3M 8,333 shares
$3,036.00
$0.38

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up